ambossIconambossIcon

Friedreich ataxia

Last updated: June 13, 2023

Summarytoggle arrow icon

Friedreich ataxia (FDRA) is an autosomal recessive disorder involving trinucleotide repeat expansion that leads to progressive neurodegeneration. It affects multiple spinal cord tracts, causing muscle weakness and impaired coordination of all limbs. A staggering gait in childhood is the resulting main symptom. Other features include skeletal abnormalities, cardiomyopathy, and diabetes. The clinical course is mainly determined by the extent of the loss of mobility and cardiac involvement. Diagnosis requires confirmation with genetic tests. Because there is no curative therapy available, the prognosis is poor.

Epidemiologytoggle arrow icon

  • The most common autosomal recessive ataxia [1]
  • Peak incidence: 8–15 years (most cases < 25 years) [2][3]
  • Affects individuals of Central and Northern European descent [2]

Epidemiological data refers to the US, unless otherwise specified.

Etiologytoggle arrow icon

References: [2][4]

Clinical featurestoggle arrow icon

Individuals with FRiedreich ATAXia have ATAXic GAAit due to the expansion of the triplet GAA in the FRATAXin gene.

Diagnosistoggle arrow icon

References:[4]

Treatmenttoggle arrow icon

References:[4]

Prognosistoggle arrow icon

References:[6]

Preventiontoggle arrow icon

  • Carrier testing of relatives
  • Prenatal testing: Genetic counseling is recommended for parents with one affected child.

References:[6]

Icon of a lock3 free articles left this month

Start a 5-day free trial or sign up for unlimited access.
 Evidence-based content, created and peer-reviewed by clinicians. Read the disclaimer